Pricing Log in Create free account

InfuSystems Holdings, Inc. (INFU) vs RxSight, Inc. (RXST)

InfuSystems Holdings, Inc. and RxSight, Inc. are both Medical Devices companies. InfuSystems Holdings, Inc. is the larger, with a market value of $270.1M against $190.4M — 1.4× the size. RxSight, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 32.0×. InfuSystems Holdings, Inc. grew revenue faster over the last twelve months: 2.47% against −14.3%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −43.8%) and the higher return on invested capital (10.6% vs −16,845.7%). Across the 21 metrics below, RxSight, Inc. leads on 12 and InfuSystems Holdings, Inc. on 9.

Valuation

Metric INFU RXST Medical Devices median
P/E 32.02 n/m 25.58
P/S 1.88 1.52 2.54
P/B 4.56 0.72 2.48
Price to free cash flow 125.85 9.91 28.81
EV/EBITDA 10.89 0.77 11.51
EV/Sales 2.02 (0.41) 2.72
Earnings yield 3.12% (28.87%) (12.82%)
Free cash flow yield 0.79% 10.09% (8.18%)

Profitability

Metric INFU RXST Medical Devices median
Gross margin 57.45% 76.13% 57.76%
Operating margin 9.26% (50.44%) (15.07%)
Net margin 5.96% (43.80%) (14.45%)
Free cash flow margin 10.56% 15.30% (3.88%)
Return on equity 15.03% (20.10%) (10.35%)
Return on assets 8.61% (16.44%) (17.26%)
Return on invested capital 10.55% (16,845.67%) (5.27%)

Growth

Metric INFU RXST Medical Devices median
Revenue growth (TTM) 2.47% (14.26%) 10.41%
EPS growth (last fiscal year) 181.82% (33.80%) 28.17%
Revenue growth, 5-year CAGR 8.05% 55.74% 15.74%
Net income growth, 5-year CAGR (17.49%) 0.00% 0.00%

Health

Metric INFU RXST Medical Devices median
Debt to equity 0.35 0.00 0.04
Current ratio 2.50 4.20 2.74
Net debt to EBITDA 0.65 4.27 0.54

Dividend

Metric INFU RXST Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric INFU RXST Medical Devices median
Market cap 270.08m 190.36m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack